地瑞那韦/达芦那韦
Darunavir (TMC114)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
200 mg 500 mg 1 g 5 g
Product Availability
In-stock
Price
$260.00
Member price
Product Availability
In-stock
Price
$350.00
Member price
Product Availability
In-stock
Price
$450.00
Member price
Product Availability
In-stock
Price
$2500.00
Member price
Quantity
- +
Product Overview
Product Name Darunavir (TMC114)
CAS206361-99-1
FormulaC₂₇H₃₇N₃O₇S
MW547.66
AppearanceWhite to off-white powder
Storage condition Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions and also inhibits the dimerization of HIV-1 protease suppressing proteolytic activity and subsequent replication of HIV-1. Study results have shown that darunavir exhibits potent inhibition against HIV-1 with a value of 50% inhibition concentration IC50 of 0.003 μmol/L in HIV-1 infected MT-2 cells. Darunavir binds to HIV-1 protease with considerably high affinity and fits closely with the substrate envelop leading to its potent ability to inhibit multidrug-resistant HIV strains. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. 


Related literature
Related
Sorry, no related items
History
Chlormethine hydrochloride | Mechlorethamine hydrochloride
Pamidronic Acid
Darunavir (TMC114)
Toddalosin
Ritodrine
SNS-032 (Synonyms: BMS-387032)
Repaglinide | AG-EE 623ZW
Sumanirole Maleate |U-95666E | PNU-95666
Pazopanib | GW786034
Rebamipide(OPC-12759;Proamipide)